Paragonix Technologies
5
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
20.0%
1 terminated/withdrawn out of 5 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Global Utilization And Registry Database for Improved preservAtion of doNor Pancreata (GUARDIAN-PANCREAS)
Role: lead
Global Utilization And Registry Database for Improved heArt preservatioN
Role: lead
Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy
Role: lead
Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
Role: lead
Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Role: lead
All 5 trials loaded